Pharmaceutical

Pharmaceutical products – more commonly known as medicines or drugs – are a fundamental component of both modern and traditional medicine. It is essential that such products are safe, effective, and of good quality, and are prescribed and used rationally.

Established in 2007, GISP Corporation is one of the leading UK pharmaceutical companies. One of our success stories is the rapid growth of the pharmaceutical division. Our focus is on both import and production of the highest-quality sport and nutritional supplements available with the goal of transferring the technology to local manufacturing. Our careful selection of products with scientifically proven effects makes us a reliable name in a wide range of supplements. Some of the most notable fields include neurology, gastroenterology, cardiac, orthopedic, women’s health, pediatric, dermatology, and many others. Our portfolio addresses a range of therapeutic areas:

Cardio Metabolic

GISP cardiovascular-metabolic therapeutic teams are passionate about research, development and quality manufacturing of novel therapies and solutions to reduce the burden of diseases in communities around the world. We focus our efforts on diseases that negatively affect the heart, kidney, liver and blood vessels with the goal of better patient outcomes.

Ophthalmology

GISP is dedicated to the research, development and manufacturing of ophthalmic pharmaceuticals and devices. The mission of GISP in the field of ophthalmology is to discover, develop and manufacture innovative products to improve eye health and enhance people’s lives.

Respiratory

Building upon our strong heritage in meeting the unmet needs of Primary Care patients, GISP is focused on improving the lives of the hundreds of millions of people with respiratory diseases. We remain committed to providing the right drug to the right patient at the right time to treat chronic obstructive pulmonary disease (COPD) and severe allergic asthma — both major public health issues.

Neuroscience

GISP has a strong 60-year history in neuroscience. We currently offer patients and physicians a large drug portfolio encompassing Multiple Sclerosis, Alzheimer’s disease, Parkinson’s Disease, Epilepsy and ADHD, and have a promising pipeline in Multiple Sclerosis, Alzheimer’s disease and Neuromuscular therapies. In our research, we leverage advances in human genetics, new imaging technologies and other novel approaches to better understand brain disorders and continue bringing pioneering drugs to patients worldwide.

Immunology and Dermatology

Our Immunology and Dermatology franchise is transforming patients’ lives by preventing progressive illnesses and successfully treating co-morbidities in the Specialty Dermatology, Rheumatology and Transplantation fields, where there are remaining high unmet medical needs.

Oncology

GISP Oncology is a leader in driving the practice of precision oncology treatment. Precision oncology is the evolving understanding of how cancers develop on a genomic level and our ability to develop drugs that hone in on those targets – ultimately leading to better patient outcomes. Our research, driven by a distinctive scientific and clinical strategy, focuses on unmet medical needs and disease pathways.

Cell and Gene Therapy

GISP Pharmaceuticals has created a dedicated unit focused on the development and commercialization of cell and gene therapies. The cell therapy portfolio aims to transform medical practice and potentially cure some patients suffering from a variety of life-threatening diseases including bloodborne cancers, sickle cell disease, thalassemias and other diseases of the blood by replacing, repopulating or resetting the immune system.